@article{9964cdc1c10f4b98b5550d349dff2b54,
title = "Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings: Radiologia Medica",
abstract = "Purpose: To report criticisms and barriers to the “real-life” application of international guidelines and recent developments in the management of locally advanced non-small cell lung cancer (NSCLC) in Italy. Methods: Three 2-day courses were organized. During the first day, experts in different fields of thoracic oncology gave their lecture on diagnosis and therapy for locally advanced NSCLC. During the second day, all participants were divided into four groups to discuss on a clinical case as a multidisciplinary team (MDT). The aim was to stimulate the discussion on practical issues in the management of NSCLC patients in the real-life practice. Results: A total of 196 physicians were involved in the courses as learners. Invasive diagnosis of nodal disease for staging purposes, a priori definition of “surgical resectability” and a regular MDT with all crucial participants available were the three main key points identified for a good management of these patients. The main barriers to the clinical application of a good diagnostic and therapeutic approach to the patient were the absence of a regular and complete MDT in the South and Centre of Italy, while in the North of Italy, time for discussion of clinical cases in the MDT and waiting lists for staging and therapeutic interventions were deemed as the major concerns. Conclusion: The meetings showed that diagnosis and treatment of locally advanced NSCLC are still extremely variable between different Italian regions. Logistic issues, waiting lists, paucity of well-trained staff and expertise seem to be the main barriers to international guidelines application. {\textcopyright} 2019, Italian Society of Medical Radiology.",
keywords = "Multidisciplinary evaluation, Non small cell lung cancer, Stage III, clinical practice, human, interdisciplinary communication, Italy, lung tumor, non small cell lung cancer, organization, patient care, practice guideline, Carcinoma, Non-Small-Cell Lung, Congresses as Topic, Humans, Interdisciplinary Communication, Lung Neoplasms, Patient Care Team, Practice Guidelines as Topic, Practice Patterns, Physicians'",
author = "D. Franceschini and A. Bruni and P. Borghetti and N. Giaj-Levra and S. Ramella and L. Buffoni and S. Badellino and M. Andolina and C. Comin and E. Vattemi and M. Bezzi and M. Trov{\`o} and A. Passaro and A. Bearz and R. Chiari and F. Tindara and K. Ferrari and G. Piperno and A.R. Filippi and D. Genovesi and V. Scotti",
note = "Cited By :2 Export Date: 3 March 2021 CODEN: RAMEA Correspondence Address: Franceschini, D.; Radiation Oncology Department, Via Manzoni 56, Italy; email: davide.franceschini@humanitas.it References: Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Bray, F., (2013) GLOBOCAN 2012 V1.0, Cancer Incidence and Mortality Worldwide, , IARC cancerbase No. 11. International Agency for Research on Cancer; Torre, L.A., Siegel, R.L., Jemal, A., Lung cancer statistics (2016) Adv Exp Med Biol, 893, pp. 1-19; Chen, V.W., Ruiz, B.A., Hsieh, M.C., Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system (2014) Cancer, 120, pp. 3781-3792; NCCN guidelines version 2.2019 Non small cell lung cancer; Postmus, P.E., Kerr, K.M., Oudkerk, M., Senan, S., Waller, D.A., Vansteenkiste, J., Escriu, C., Peters, S., Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2017) Ann Oncol, 28, pp. iv1-iv21; Bruni, A., Grossi, F., Ferrari, K., The standard of care for stage III NSCLC in the era of immunotherapy: An Italian national survey on the current pattern of care among Italian thoracic oncologists (2018) Ann Oncol, 29, pp. 291-013; Lipmanowicz, H., McCandless, K., (2014) The surprising power of liberating structures: simple rules to unleash a culture of innovation, , Liberating Structures Press, Seattle; Antonia, S.J., Villegas, A., Daniel, D., Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC (2018) N Engl J Med, 379 (24), pp. 2342-2350. , COI: 1:CAS:528:DC%2BC1MXltF2nsw%3D%3D; Ramnath, N., Dilling, T.J., Harris, L.J., Treatment of stage III non-small cell lung cancer diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines (2013) Chest, 143, pp. e314S-e340S. , COI: 1:CAS:528:DC%2BC3sXosFKmtrs%3D; Cerfolio, R.J., Maniscalco, L., Bryant, A.S., The treatment of patients with stage IIIA non-small cell lung cancer from N2 disease: who returns to the surgical arena and who survives (2008) Ann Thorac Surg, 86, pp. 912-920; Bueno, R., Richards, W.G., Swanson, S.J., Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival (2000) Ann Thorac Surg, 70, pp. 1826-1831. , COI: 1:STN:280:DC%2BD3M%2FpvFersQ%3D%3D; Kim, S.H., Lee, J.H., Lee, G.J., Interpretation and prognostic value of positron emission tomography-computed tomography after induction chemotherapy with or without radiation in IIIA-N2 non-small cell lung cancer patients who receive curative surgery (2015) Medicine (Baltimore), 94 (24). , COI: 1:CAS:528:DC%2BC2MXhtVOnu77F; Auperin, A., Le Pechoux, C., Rolland, E., Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small cell lung cancer (2010) J Clin Oncol, 28, pp. 2181-2190. , COI: 1:CAS:528:DC%2BC3cXpsFSgsbY%3D; Tamburini, N., Maniscalco, P., Mazzara, S., Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study (2017) Eur J Cardiothorac Surg, 53 (6), pp. 1199-1204; Nwaejike, N., Elbur, E., Malagon, I., Is there a role for the high-risk multidisciplinary team meeting in thoracic surgery? (2016) Interact Cardiol Vasc Thorac Surg, 22, pp. 397-401; Gridelli, C., Balducci, L., Ciardiello, F., Treatment of elderly patients with non-small-cell lung cancer: results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology (2015) Clin Lung Cancer, 16, pp. 325-333; Wildiers, H., Heeren, P., Puts, M., International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer (2014) J Clin Oncol, 32, pp. 2595-2603; Hurria, A., Wildes, T., Blair, S.L., Senior adult oncology, version 2.2014: Clinical practice guidelines in oncology (2018) Elderly Patients with Advanced NSCLC: The Value of Geriatric Evaluation and The Feasibility of CGA Alternatives in Predicting Chemotherapy Toxicity. Pulmonology",
year = "2020",
doi = "10.1007/s11547-019-01094-w",
language = "English",
volume = "125",
pages = "214--219",
journal = "Radiol. Med.",
issn = "0033-8362",
publisher = "Springer",
number = "2",
}